Results 91 to 100 of about 1,739 (165)

Randomized phase-II trial of surufatinib plus FOLFOX/FOLFIRI versus FOLFOXIRI as second-line therapy for metastatic colorectal cancer. [PDF]

open access: yesAnn Med
Su L   +13 more
europepmc   +1 more source

Learn Then Decide: A Learning Approach for Designing Data Marketplaces. [PDF]

open access: yesJ Am Stat Assoc
Gao Y   +5 more
europepmc   +1 more source

Home - About - Disclaimer - Privacy